Washington Post: Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients, study says

By AIRIANA EUNJUNG CHA and LAURIE McGINLEY

A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a “game changer” in the fight against the virus had a significantly higher risk of death compared with those who did not.

People treated with hydroxychloroquine, or the closely related drug chloroquine, were also more likely to develop a type of irregular heart rhythm, or arrhythmia, that can lead to sudden cardiac death, it concluded.

Read more here.